Summary
Xiaofeng Zheng is a postdoctoral fellow at MD Anderson Cancer Center with a decade of research experience focused on epithelial-to-mesenchymal transition, tumor metastasis, and pancreatic cancer biology. Trained with a Ph.D. in Developmental Biology from Tsinghua University and a bachelor's in Biotechnology from Sichuan University, he brings deep expertise in tumor microenvironment, immunology, and therapeutic responses to immunotherapy and chemotherapy. His work bridges fundamental developmental mechanisms and translational cancer research, aiming to uncover how cellular plasticity drives metastatic progression and therapy resistance. Based in Houston, he combines rigorous academic training with sustained bench-to-bedside thinking, often integrating immunological perspectives into cancer biology studies. An investigator who balances mechanistic curiosity with clinical relevance, he is positioned to advance targeted strategies against aggressive tumor phenotypes.
10 years of coding experience
Bachelor’s Degree, Biotechnology, Bachelor’s Degree, Biotechnology at Sichuan University
Doctor of Philosophy (Ph.D.), Developmental Biology, Doctor of Philosophy (Ph.D.), Developmental Biology at Tsinghua University